| Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C (ut) annabinoid” System KF Tóth, D Ádám, T Bíró, A Oláh Molecules 24 (5), 918, 2019 | 257 | 2019 |
| Opioidergic signaling—a neglected, yet potentially important player in atopic dermatitis D Ádám, J Arany, KF Tóth, BI Tóth, AG Szöllősi, A Oláh International Journal of Molecular Sciences 23 (8), 4140, 2022 | 14 | 2022 |
| GPR119 is a potent regulator of human sebocyte biology A Markovics, Á Angyal, KF Tóth, D Ádám, Z Pénzes, J Magi, Á Pór, ... Journal of Investigative Dermatology 140 (10), 1909-1918. e8, 2020 | 14 | 2020 |
| Mannich-type modifications of (−)-cannabidiol and (−)-cannabigerol leading to new, bioactive derivatives EB Lőrincz, G Tóth, J Spolárics, M Herczeg, J Hodek, I Zupkó, R Minorics, ... Scientific Reports 13 (1), 19618, 2023 | 8 | 2023 |
| 607 The putative tribbles homolog 3 (TRIB3) activator honokiol suppresses lipogenesis, and exerts anti-proliferative as well as anti-inflammatory effects on human sebocytes K Toth, D Adam, J Arany, P Faragó, JL Arbiser, CC Zouboulis, T Bíró, ... Journal of Investigative Dermatology 139 (9), S319, 2019 | 2 | 2019 |
| Fluoxetine exerts anti‐inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release KF Tóth, D Ádám, J Arany, YA Ramirez, T Bíró, JI Drake, A O'Mahony, ... Experimental Dermatology 33 (1), e14988, 2024 | 1 | 2024 |
| Activation of k-opioid receptor (KOR) suppresses pro-inflammatory response of human epidermal keratinocytes D Ádám, KF Tóth, F Sárkány, M Soeberdt, C Abels, A Oláh, T Bíró EXPERIMENTAL DERMATOLOGY 27, 2018 | 1 | 2018 |
| Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes D Ádám, J Arany, KF Tóth, S Póliska, J Váradi, P Kolozsi, D Tóth, ... Archives of Dermatological Research 317 (1), 277, 2025 | | 2025 |
| 495 The TRPM5 antagonist triphenylphosphine oxide increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner D Ádám, J Arany, KF Tóth, O Petö, T Nyitrai, BI Tóth, S Póliska, ... Journal of Investigative Dermatology 144 (12), S313, 2024 | | 2024 |
| 213 Sebum lipids selectively modulate gene expression in keratinocytes K Dull, D Ádám, S Póliska, H Aboud, A Szegedi, A Oláh, D Töröcsik Journal of Investigative Dermatology 144 (12), S264, 2024 | | 2024 |
| 136 Adenosine receptors are novel regulators of human sebocyte biology J Arany, D Ádám, M Cseszlai, T Nyitrai, CC Zouboulis, HA Oláh Journal of Investigative Dermatology 143 (11), S355, 2023 | | 2023 |
| 173 Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses their endothelin release KF Tóth, D Ádám, J Arany, YA Ramirez, T Bíró, JI Drake, A O’Mahony, ... Journal of Investigative Dermatology 143 (11), S361, 2023 | | 2023 |
| 131 The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades D Ádám, J Arany, O Pető, BI Tóth, CC Zouboulis, HA Oláh Journal of Investigative Dermatology 143 (11), S354, 2023 | | 2023 |
| 731 Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses endothelin release via inhibiting PI3K K Tóth, D Ádám, J Arany, YA Ramirez, T Bíró, JI Drake, A O’Mahony, ... Journal of Investigative Dermatology 143 (5), S126, 2023 | | 2023 |
| GPR119 is a potent novel regulator of human sebocyte biology KF Toth, A Markovics, D Adam, Z Penzes, A Angyal, J Magi, A Poor, ... EXPERIMENTAL DERMATOLOGY 27, 36-37, 2018 | | 2018 |
| Genetikai mintázat és képalkotás összefüggései gliomák esetében D Ádám | | 2017 |
| Mannich-type modifications of (−)-cannabidiol and (−)-cannabigerol leading to new, bioactive derivatives T Gergely, EB Lőrincz, J Spolárics, M Herczeg, A Borbás, P Herczegh, ... | | |
| A gerinc képalkotó vizsgálata-modern és paleoradiológiai megközelítés D Ádám | | |
Attila OláhAssociate Professor at the University of Debrecen, Department of PhysiologyAdresse e-mail validée de med.unideb.hu